Avani Athauda, MBBS, MRCP, The Royal Marsden NHS Foundation Trust, London, UK, explains the importance of a personalized approach to the management of patients with early esophagogastric cancer in order to reduce the rate of relapse following treatment with chemotherapy and surgery. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).